Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 171

The DOI matches its Crossref record.

AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients

Open access
Scholten, Eduard M., Cremers, Serge C.L.M., Schoemaker, Rik C., Rowshani, Ajda T., van Kan, Erik J., den Hartigh, J.A.N., Paul, Leendert C., de Fijter, Johan W. · 2005 · Kidney International

Abstract

BACKGROUND Tacrolimus has a narrow therapeutic window, and bioavailability is known to vary considerably between renal transplant recipients. Most centers still rely on measurement of trough levels, but there are conflicting reports on the correlation between tacrolimus trough levels and systemic exposure, as measured by the area-under-the-concentration-over-time curve (AUC((0-12h))). METHODS We developed and validated a two-compartmental population-based pharmacokinetic model with Bayesian estimation of tacrolimus systemic exposure. Subsequently, we used this model to apply prospectively AUC-guided dosing of tacrolimus in 15 consecutive renal transplant recipients. The main objective was to study intrapatient variability in the course of time. RESULTS Bayesian forecasting with a two-point sampling strategy, a trough level, and a second sample obtained between two and four hours post-dose significantly improved the squared correlation with the AUC((0-12h)) (r(2)= 0.94). Compared with trough level monitoring only, this approach reduced the 95%-prediction interval by 50%. The Bayesian approach proved to be feasible in clinical practice, and provided accurate information about systemic tacrolimus exposure in individual patients. In the AUC-guided dosing cohort the apparent clearance of tacrolimus decreased gradually over time, which was not reflected in corresponding trough levels. CONCLUSION This simple, flexible method provides the opportunity to tailor immunosuppression, and should help minimize tacrolimus-related toxicity, such as nephrotoxicity and post-transplant diabetes mellitus.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1523-1755.2005.00352.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 171

Metadata

Authors
Scholten, E. M., Cremers, S. C. L. M., Schoemaker, R. C., Rowshani, A. T., van Kan, E. J., den Hartigh, J. A. N., Paul, L. C., & de Fijter, J. W.
Venue
Kidney International
Publisher
Elsevier BV
Published
2005-06
Volume
67
Issue
6
Pages
2440-2447
ISSN
0085-2538 (ISSN-L)
OpenAlex
W2096799462
Cited by
171
References
0
FWCI
3.02
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients. https://app.cochat.ai/papers/10.1111/j.1523-1755.2005.00352.x
The paper
Scholten, E. M., Cremers, S. C. L. M., Schoemaker, R. C., Rowshani, A. T., van Kan, E. J., den Hartigh, J. A. N., Paul, L. C., & de Fijter, J. W. (2005). AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients. Kidney International. https://doi.org/10.1111/j.1523-1755.2005.00352.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.